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Osteoarthritis (OA), characterized by debilitating joint pain, is a degenerative 
disease caused by the breakdown of cartilage in joints and adjacent bone. It is the most 
common type of arthritis, affecting 10-12% of the US adult population, and currently has 
no cure (Lawrence, et al.). Cartilage contains specialized molecules called 
proteoglycans (PGs). PGs are vital suppliers of swelling pressure that enable cartilage 
to withstand compressional forces applied by adjacent bones. A decrease in cartilage 
PG content can signal the subsequent onset of osteoarthritis. Current methods of OA 
therapy evaluation are destructive, however due to the degenerative nature of OA the 
longitudinal evaluation of therapies is crucial. EPIC- μCT (equilibrium partitioning of 
ionic contrasting agent – microcomputed tomography), is a volumetric, non-destructive 
imaging method. This method utilizes a contrast agent (Hexabrix 320 30%) that yields 
an equilibrium distribution that is inversely proportional to the density of PGs (Palmer, et 
al.) allowing for the quantification of PGs in neocartilage constructs. An EPIC- μCT 
method for analyzing proteoglycan content in neocartilage constructs would allow for 
the longitudinal evaluation of novel osteoarthritis therapies.  
 
To develop this model, neocartilage constructs were created from bovine 
chondrocytes and cultured to 17 days in serum-free media. PG content was then 
assessed at 6, 12, and 17 days using the EPIC-uCT method. Results have shown that 
constructs were not affected by longitudinal scanning and reached equilibration in 
Hexabrix after 30 minutes of incubation. A negative correlation was also found to exist 
between neocartilage PG content and x-ray attenuation. Current research is being 










Osteoarthritis (OA), characterized by debilitating joint pain, is a degenerative 
disease that is caused by the breakdown of cartilage in joints and adjacent bone. It is 
the most common type of arthritis, affecting 9.6% of men and 18% of women over 60 
(Palazaro et al, 2014). Additionally, the total number of people afflicted with OA is 
projected to increase due to the aging population and the rise in obesity rates (Zhang et 
al, 2011). Although this disease affects this portion of the population and has been 
shown to be associated with increased mortality, there is currently no cure and only pain 
management treatments are available (Nuesch et al, 2011).  
Proteoglycans (PGs) are well suited for diagnosing the onset of OA in cartilage 
and for evaluating cartilage repair by novel OA therapies (Palmer et al, 2006). PGs 
provide swelling pressure that enables the cartilage and therefore the joint to withstand 
compressional forces applied by the adjacent bones. A decrease in sulphated 
glycosaminoglycans (sGAGs), a negatively charged molecule linked to the PG 
backbone (Plaas, 1998), can denote a decrease in cartilage PG content from the 
extracellular matrix (ECM). Changes in the ECM composition have also shown to alter 
the biomechanical properties of the ECM (Setton, 1993) (Williamson, 2001), which can 
indicate the vitality of the articular cartilage and the progression of OA.  
The ability to accurately quantify the morphologic changes in small animals like 
rats is crucial to the development and evaluation of new therapies for OA (Xie, 2009). 
Morphologic changes in cartilage ECM can be detected with histology or protein assays, 
but these methods are destructive. Nondestructive techniques like magnetic resonance 
imaging (MRI) and ultrasonography are adequate for measuring changes in humans, 
but do not provide adequate resolution for small animal models (Watrin et al, 2001) 
(Watrin-Pinzano, 2005). Optical coherence tomography (OCT) provides the needed 
resolution for rat cartilage but only produces two dimensional (2D) images (Jurvelin et 
al, 1995). EPIC- μCT (equilibrium partitioning of ionic contrasting agent – 
microcomputed tomography), is a volumetric, non-destructive method that allows for the 
longitudinal analysis of sGAG content in cartilage (Palmer et al, 2006). Because of the 
low radiopacity of soft tissues, μCT had previously not been used to analyze cartilage. 
However, EPIC- μCT uses a negatively charged contrast agent (Hexabrix 320 30%) that 
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yields an equilibrium distribution that is inversely proportional to the density of the 
negatively charged sGAGs (Palmer et al, 2006). EPIC- μCT is now used quantify and 
monitor changes in rat articular cartilage structure pre and post therapeutic exposure 
(Thote, 2013).  
While small animal studies involving rats are the ‘gold standard’ of therapeutic 
evaluation, the use of in-vitro models prior provides preliminary results that can be 
assessed in less time and at a lesser cost. It is to this effect that a variety of in-vitro 
methods have been developed although with little regularity between researchers due to 
the need to tailor in-vitro models to reflect in-vivo disease (Johnson et al, 2016). While 
various methods of effective cartilage modeling have been used such as explants, 
neocartilage constructs created from functional articular chondrocytes of either bovine 
or human type, have been shown to display similar biomechanical properties of 
cartilage in-vivo (Huang, 2015) and are not limited by availability of explant harvests. 
The majority of in-vitro models can be categorized into models that use applied 
cytokines and models that use applied loads to induce OA symptoms. While applied 
load models are easily manipulated, they ultimately result in the release of inflammatory 
cytokines like interleukin (IL)-1β and tumor necrosis factor (TNF)-α after the integrin 
stimulated stress pathway is induced (Bader et al, 2011). Applied cytokine models skip 
to the end stage symptoms of OA ignoring potential early stage protective solutions. 
However, due to the OA-like biological changes that applied cytokines elicit, this model 
is an inexpensive and easily manipulated method for analyzing the temporal and 
concentration effects of novel therapies (Johnson et al, 2016). IL-1β and TNF-α are the 
mostly commonly used cytokines for inducing OA symptoms. Although other cytokines 
may play a role in inflammation caused by OA, they aren’t as frequently used as they 
can be derived from IL-1β and TNF-α.  
With the expense and significant investment it takes to implement rat models of 
OA, an accurate and efficient in-vitro method is needed that mimics the volumetric and 
non-destructive conditions of the EPIC- μCT method. An EPIC- μCT method for 
analyzing proteoglycan content in neocartilage constructs would allow for the 
longitudinal evaluation of novel osteoarthritis therapies.  To demonstrate the potential of 
this approach to examine if neocartilage constructs can adequately capture the 
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longitudinal degradation of cartilage seen in OA patients, we first present data validating 
the ability of the constructs to produce PGs as they grow and to display a negative 
correlation between x-ray attenuation and sGAG content. Second, we present data 
illustrating the effects of exposing the neocartilage constructs to interleukins-beta (IL-
1β), a known inflammatory cytokine, to stimulate the degradation of PGs in cartilage 
during the onset of OA. Lastly we will expose the constructs to a previously quantified 
therapeutic after exposure to IL-1β to then assess the efficacy of the method at 

























Methods and Materials 
 
Media and Size 
In phase I, bovine chondrocyte (Asarte Biologics LLC) pellets were created by 
centrifuging cells at 500G for 5 minutes. Pellets needed to be constructed and cultured 
in order to withstand the subsequent longitudinal scanning procedures. Pellets of 250k 
and 500k cells cultured for three weeks in media with and without fetal bovine serum 
(FBS) were compared (Table 1). They were fed 3 times per week. Media with FBS 
contained Dulbecco’s Modified Eagle Media (DMEM) without sodium pyruvate, FBS 
(10%), penicillin streptomycin (1%), nonessential amino acids (1%), gentamycin (0.1%), 
and L-ascorbic acid 2-phosphate (50 ng/mL). Media without FBS contained DMEM with 
sodium pyruvate, ITS+ (1%), nonessential amino acids (1%), gentamycin (0.1%), 
dexamethasone (100 mM), and L-ascorbic acid 2-phosphate (50 ng/mL).  
 
 500k cells 250k cells 
With 
Serum 
4 pellets 4 pellets 
Without 
Serum 




To determine the average equilibration time needed for pellets in contrast agent 
(30% Hexabrix, PBS) six pellets were cultured for three weeks in serum free media and 
fed 3 times per week. Pellets were then incubated in contrast agent (30% Hexabrix, 
PBS) for additive time periods (15, 30, 45, 60, 90 minutes) and then scanned using a 
Scanco Medical uCT40.  
Scanning Effects 
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 Pellets were cultured for three weeks and fed 3 times per week. At each time 
point a set number of pellets were scanned and removed from culture to be frozen for 
assaying. A set number of pellets at each time point were fixed and saved for histology. 
3 pellets were not scanned until the last time point in order to serve a control for the 
longitudinal effects of scanning.  
 
Days Scan & 
Assay 
Histology Scan & 
Assay Only 
7 5 1  
14 5 1  
21 5 2 3 
Table 2 
 
Dimethylmethylene Blue Assay (DMMB) 
Pellets saved for assaying were digested overnight at 60 degrees Celsius in 180 
uL of proteinase K buffer (30 mM Tris Cl, 30 mM EDTA,  5% Tween 20, 0.5% triton x-
100 and 800 mM GuHCl) and 20 uL of proteinase K. A DMMB assay was then 





























Figure 1. Average Equilibration Time of Neocartilage Constructs. After incubation in Hexabrix (30%) 
contrast agent, constructs made with 500,000 cells were found to have an average equilibration time of 





Figure 2. Phase I Histology. Saffarin-O histology was performed after 21 days of culturing on 500,000 cell 
constructs cultured in media without fetal bovine serum (FBS)(left) and with FBS (right) to determine ideal 








Scanning Effect on sGAG Content 
 
Figure 3. Scanning Effect on sGAG Content. A group of constructs was scanned at each time point for a 
total of three times. A second group was scanned at one time point, and a control group was not scanned 
during the culturing process. There was no significant difference between groups. N=4, one-way ANOVA 
used.  
 
Longitudinal sGAG Content in Neocartilage Constructs 
 
 
Figure 4.  Longitudinal sGAG Content in Neocartilage Constructs. The results of a DMMB assay to 
quantify sGAG content in neocartilage constructs displays a significant difference between groups of 
pellets that were cultured to different time points. N=3,4, one-way ANOVA used. *statistically significant 
difference from 7-day treatment group.  
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Longitudinal uCT Attenuation in Neocartilage Constructs 
 
Figure 5. Longitudinal uCT Attenuation in Neocartilage Constructs. Neocartilage constructs that were 
cultured to and scanned at three different time points displayed a significant difference between 6 and 12 
days and 6 and 17 days. N=3,4, one-way ANOVA used. *statistically significant difference from 7-day 
treatment group.  
  




Figure 6. Neocartilage Construct sGAG Content vs. uCT Attenuation. The uCT attenuation of each 








There are two common types of culture media for articular bovine chondrocytes, 
one containing fetal bovine serum (FBS) and one that does not. FBS contains a 
complex array of growth factors and proteins intended to aid cell growth. However, it 
was found that this uncharacterized array of growth factors could have contributed to 
the suppression of proteoglycans in cells cultured in media with FBS. This is evidenced 
by the deep red of proteoglycan expression in pellets cultured in media without FBS as 
seen in Figure 2. As proteoglycans are essential for cartilage vitality, media without FBS 
was chosen for the remainder of experiments.   
The average construct equilibration time was determined from the average 
attenuation coefficient for each construct. This component of phase I was necessary to 
fully saturate the pellet with contrast agent in order to ensure a reliable correlation 
between uCT attenuation and sGAG content. The average construct equilibration time 
was found to be 30 minutes, which seems long as previous experiments conducted 
using full rabbit tibias also used an equilibration time of 30 minutes (Palmer et al, 2006). 
However, despite the seemingly extended equilibration time, 30 minutes was chosen for 





After comparing the sGAG content of groups of constructs that were scanned at 
differing time points to a control group that was not scanned, no statistically significant 
difference was seen between groups. Similar results that show scanning does not have 
a significant effect on proteoglycan content has also been seen in in-vivo studies 
(Palmer et al, 2006).  
 The results of a DMMB assay to quantify sGAG content of neocartilage 
constructs showed an increasing trend, yet did not yield statistically significant results 
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between groups. This is problematic as it’s assumed the volume of pellets, acquired by 
culturing overtime, should display a positive correlation to sGAG and therefore 
proteoglycan content.  
 When uCT attenuation results of neocartilage constructs were analyzed, a 
statistically significant difference was found between groups scanned at day 7 and 14, 
and 7 and 21. This suggests that pellets are growing, however based on 
aforementioned DMMB assay results the contents of the pellet growth cannot be 
determined. In order to determine the contents of the pellet growth, the DMMB assay 
should be refined and repeated. When uCT attenuation is plotted against the sGAG 
content of constructs, a weak negative correlation is observed. This could be improved 
by a more sensitive DMMB assay to capture a comprehensive quantification of 























Quality neocartilage constructs that have the ability to withstand longitudinal 
scanning procedures can be cultured in serum-less media, while equilibration time 
occurs after 30 minutes of incubation in the EPIC-uCT contrast agent, Hexabrix (30%). 
In addition, scanning does not have a longitudinal effect on proteoglycan content in 
neocartilage constructs. Neocartilage constructs displayed a decreased attenuation 
over time, suggesting an increase in sGAG content. However, results from the DMMB 
assay do not support this hypothesis and show that there was no statistically significant 
difference in sGAG conent of pellets cultured to and scanned at increasing time points. 
Although a weak negative correlation does exist between sGAG content and attenuation 
experiments should be repeated to ensure that sGAG quantification methods are 
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